Oorsprong van het eerstegraads netwerk van Gordon Brooks
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Gordon Brooks via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Miscellaneous Commercial Services | Chairman Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Operating Officer Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
DICE Molecules SV, Inc.
 DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Investment Managers | Director/Board Member Chairman Chief Executive Officer Director/Board Member Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
POINT Biopharma Corp.
 POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation. | Miscellaneous Commercial Services | Chairman Director/Board Member Chief Tech/Sci/R&D Officer Founder | |
| SIGILON THERAPEUTICS, INC. | Biotechnology | President Director/Board Member Corporate Secretary | |
| Stanford University | College/University | Masters Business Admin Corporate Officer/Principal Doctorate Degree | |
| McMaster University | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| University of Toronto | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree | |
DiCE Molecules, Inc.
 DiCE Molecules, Inc. Packaged SoftwareTechnology Services DiCE Molecules, Inc. is a private company that focuses on immunology and small molecule discovery. The company is based in Menlo Park, CA. The company's goal is to provide convenient oral medicines with biologic-like efficacy to patients with chronic diseases. The company was founded by J. Kevin Judice and he has been the CEO since incorporation. | Packaged Software | Director/Board Member Chief Executive Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Graduate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Director/Board Member Undergraduate Degree | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Yale School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
Verity Pharmaceuticals, Inc.
 Verity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verity Pharmaceuticals, Inc. operates as a pharmaceutical company. It provides therapeutically relevant agents to the Canadian healthcare community. The company was founded in 2016 and is headquartered in Mississauga, ON. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Wilfrid Laurier University | College/University | Undergraduate Degree Undergraduate Degree | |
| AKOUOS | Biotechnology | President | |
Tract Pharmaceuticals, Inc.
 Tract Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tract Pharmaceuticals, Inc. is a pharmaceutical manufacturing company founded in 2016. The private company is based in West Hartford, CT. The company manufactures pharmaceuticals. | Pharmaceuticals: Major | Director/Board Member | |
Synergex Corp.
 Synergex Corp. Air Freight/CouriersTransportation Synergex Corp. provides supply chain management services in Latin America. It specializes in logistics services, distribution, licensing, sales, localization, packaging and marketing of digital entertainment products. The company was founded in 1986 and is headquartered in Mississauga, Canada. | Air Freight/Couriers | Director/Board Member | |
University Health Network
 University Health Network Hospital/Nursing ManagementHealth Services University Health Network operates as a healthcare and medical research organization that provides patient care, education, and research services. Its programs include arthritis program, joint department of medical imaging, Krembil neuroscience center, laboratory medicine program, medical and community care, multi-organ transplant, Peter Munk cardiac center, Princess Margaret cancer, surgery and critical care program, and Toronto rehab. The company was founded in 1986 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Princess Margaret Hospital | Corporate Officer/Principal | ||
Canadian Urologic Oncology Group
 Canadian Urologic Oncology Group BiotechnologyHealth Technology Canadian Urologic Oncology Group operates as a clinical research investigator network. The company is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member | |
| OCATA THERAPEUTICS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Worcester Polytechnic Institute | College/University | Undergraduate Degree | |
| Tufts University School of Medicine | College/University | Doctorate Degree | |
| Suffolk University Law School | College/University | Graduate Degree | |
| Harvard Law School | College/University | Graduate Degree | |
Seeing Medicines, Inc.
 Seeing Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Seeing Medicines, Inc. is a preclinical-stage biotechnology company that develops regenerative medicine treatments to restore and maintain vision in people. The company is based in Arden, NC. Seeing Medicines was founded by Lucian Del Priore, Andrew Fowlie, Matthew Vincent, H. LeRoux Jooste, Edmund V. Mickunas. H. LeRoux Jooste has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
| NEVRO CORP. | Medical Specialties | Corporate Officer/Principal | |
Makesense Digital Health Ltd.
 Makesense Digital Health Ltd. Packaged SoftwareTechnology Services MakeSense Digital Health Ltd was founded by Alex Tolmach and Lior Eshel, with Lior Eshel serving as CEO since incorporation. The Israeli company develops an AI-based nutritional monitoring technology that allows users to measure the nutritional value of their meals without the need for manual meal-logging in a food diary. | Packaged Software | Director/Board Member | |
The American Chamber of Commerce in Japan
 The American Chamber of Commerce in Japan Miscellaneous Commercial ServicesCommercial Services The American Chamber of Commerce in Japan is a Chamber of Commerce. The non-profit company is based in Minato-ku, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
Eli Lilly Italia SpA
 Eli Lilly Italia SpA Pharmaceuticals: MajorHealth Technology Eli Lilly Italia SpA manufactures pharmaceutical products. The company was founded by Colonel Eli Lilly in 1876 and is headquartered in Sesto Fiorentino, Italy. | Pharmaceuticals: Major | Chief Executive Officer | |
| DERMIRA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Deutsche Bank Corp.
 Deutsche Bank Corp. Regional BanksFinance Part of Deutsche Bank AG, Deutsche Bank Corp. is a company based in New York, NY. | Regional Banks | Corporate Officer/Principal | |
| ARMO BIOSCIENCES INC | Pharmaceuticals: Major | Chief Executive Officer | |
| Lund University School of Economics & Management | College/University | Undergraduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Investor Relations Contact | |
| PURPLE BIOTECH LTD | Pharmaceuticals: Major | Director/Board Member | |
Quris Technologies Ltd.
 Quris Technologies Ltd. Packaged SoftwareTechnology Services Quris Technologies Ltd. is a company based in Tel Aviv, Israel that is revolutionizing the drug development process by pioneering clinical trials on chips. The Israeli company tests thousands of novel drug candidates on hundreds of miniaturized "patients-on-a-chip" using their fully automated, self-training AI platform. This platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively than ever before, all while minimizing animal testing. The company was founded by Isaac Bentwich and Yossi Haran, and Isaac Bentwich has been the CEO since incorporation. | Packaged Software | Director/Board Member | |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
Neuron23, Inc.
 Neuron23, Inc. Miscellaneous Commercial ServicesCommercial Services Neuron23, Inc. is a clinical-stage biotechnology company based in an undisclosed location. The American company's focus areas are neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Neuron23 combines recent advances in human genetics with a state-of-the-art drug discovery and biomarker platform using advanced techniques in machine learning and artificial intelligence to advance therapeutics for devastating diseases. The company was founded by Adam Knight and Nancy E. Stagliano has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 34 |
| Canada | 10 |
| Israël | 5 |
| Verenigd Koninkrijk | 2 |
| Japan | 2 |
Sectoraal
| Health Technology | 21 |
| Consumer Services | 15 |
| Commercial Services | 7 |
| Finance | 5 |
| Technology Services | 4 |
Operationeel
| Director/Board Member | 119 |
| Corporate Officer/Principal | 59 |
| Independent Dir/Board Member | 37 |
| Undergraduate Degree | 26 |
| Chief Tech/Sci/R&D Officer | 26 |
Sterkste connecties
| Insiders | |
|---|---|
| Richard Scheller | 27 |
| Jim Scopa | 26 |
| Jonathan Goodman | 25 |
| Sharon Tetlow | 21 |
| David Lubner | 19 |
| Yael Margolin | 16 |
| Allan Silber | 15 |
| Philip Johnson | 13 |
| Jake Simson | 11 |
| J. Judice | 10 |
| Rajesh K. Malik | 10 |
| Neil Fleshner | 10 |
| Lisa Bowers | 8 |
| Mittie Doyle | 8 |
| Daniel Pearlstein | 8 |
- Beurs
- Insiders
- Gordon Brooks
- Bedrijfsconnecties
